60 related articles for article (PubMed ID: 206043)
1. [Cyclic 3'-5'-AMP and prostaglandin-endoperoxide in thrombocytes of patients with circulatory insufficiency and shock].
Matthias FR; Schöndorf T
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1158-61. PubMed ID: 206043
[No Abstract] [Full Text] [Related]
2. Endogenous antiaggregatory prostaglandins can contribute to inhibition of hemostasis: a pharmacological study in vivo in humans.
Gresele P; Arnout J; Deckmyn H; Vermylen J
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():248-53. PubMed ID: 2821758
[No Abstract] [Full Text] [Related]
3. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
Baluda VP; Sushkevich GN; Lukoianova TI
Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
[No Abstract] [Full Text] [Related]
4. Contribution of arachidonic acid metabolites to atherosclerosis.
Dembińska-Kieć A; Gryglewski RJ
Wien Klin Wochenschr; 1986 Apr; 98(7):198-206. PubMed ID: 3010578
[TBL] [Abstract][Full Text] [Related]
5. Novel prostaglandin endoperoxide analogs having prostacyclin-like actions on platelets from human and horse but not from rat and rabbit.
Wilson NH; Armstrong RA; Jones RL
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():491-5. PubMed ID: 2821762
[No Abstract] [Full Text] [Related]
6. Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.
Raz A; Aharony D
Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):507-15. PubMed ID: 705027
[TBL] [Abstract][Full Text] [Related]
7. Soluble plasma fibrin and platelet prostaglandin endoperoxides following myocardial infarction.
Matthias FR
Haemostasis; 1978; 7(5):273-81. PubMed ID: 689490
[TBL] [Abstract][Full Text] [Related]
8. Ethanol inhibits the formation of endoperoxide metabolites in human platelets.
Hwang DH
Prostaglandins Med; 1981 Dec; 7(6):511-3. PubMed ID: 7323210
[No Abstract] [Full Text] [Related]
9. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
Siegl AM; Daly JW
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
[TBL] [Abstract][Full Text] [Related]
10. Regulation of phospholipase activity in platelets.
Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecasas P
Adv Prostaglandin Thromboxane Res; 1978; 3():127-35. PubMed ID: 207172
[No Abstract] [Full Text] [Related]
11. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
12. [Effect of dikvertin on the cyclic nucleotide level in thrombocytes].
Kubatiev AA; Iadigarova ZT; Rud'ko IA; Bykov VA; Tiukavkina NA
Biull Eksp Biol Med; 1999 Sep; 128(9):267-9. PubMed ID: 10560042
[No Abstract] [Full Text] [Related]
13. [Hemostatic properties of thrombocytes and their cyclic 3,5-adenosine monophosphate and prostaglandin E2 content during the storage of preserved blood at 4 degrees C].
Sushkevich GN; Chebotarevskaia LV; Siatkovskiĭ VA
Probl Gematol Pereliv Krovi; 1982 Jun; 27(6):21-3. PubMed ID: 6287450
[No Abstract] [Full Text] [Related]
14. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
Basevich VV; Mevkh AT; Varfolomeev SD
Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2 and prostaglandin H2 form covalently linked derivatives with human serum albumin.
Maclouf J; Kindahl H; Granström E; Samuelsson B
Adv Prostaglandin Thromboxane Res; 1980; 6():283-6. PubMed ID: 7386268
[No Abstract] [Full Text] [Related]
16. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets.
Macfarlane DE; Mills DC
J Cyclic Nucleotide Res; 1981; 7(1):1-11. PubMed ID: 6265510
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
[No Abstract] [Full Text] [Related]
18. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
Ashby B
Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP metabolism in intact platelets determined by 18O incorporation into adenine nucleotide alpha-phosphoryls.
Goldberg ND; Walseth TF; Eide SJ; Krick TP; Kuehn BL; Gander JE
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():363-79. PubMed ID: 6202126
[No Abstract] [Full Text] [Related]
20. Platelet function in health and disease.
Hirsh J; Doery JC
Prog Hematol; 1971; 7():185-234. PubMed ID: 4363291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
